"The percentage of U.S. adults taking anxiety medication has surged, particularly during the pandemic, leading to a national debate about the efficacy and safety of these treatments."
The past few years have witnessed a significant increase in the number of Americans seeking relief from anxiety, with a notable rise in the prescription and use of anti-anxiety medications. Data from the Centers for Disease Control and Prevention (CDC) reveals a jump from 11.7% in 2019 to 14.3% in 2024, translating to approximately 8 million more individuals relying on these treatments. This trend, largely amplified by the stresses of the COVID-19 pandemic, spans various demographics, including young adults, college graduates, and the LGBTQ+ community. However, this surge has also ignited a vigorous discussion, with some public health advocates questioning the widespread use of certain antidepressants, particularly Selective Serotonin Reuptake Inhibitors (SSRIs), while medical professionals largely defend them as safe and effective first-line treatments.
Sadia Zapp, a 40-year-old communications director from New York, exemplifies the experience of many. Following a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Zapp found herself grappling with an anxiety that transcended everyday worries. "Every little ache, like a knee pain, would make me think: this is the end of the road for me," she recounted. This profound unease led her to join the millions of Americans who have turned to anti-anxiety medications. For Zapp, Lexapro, an SSRI that enhances serotonin production, has been a transformative aid. "I love it. It’s been excellent," she stated, emphasizing its crucial role in managing her anxiety.
The growing acceptance and accessibility of psychiatric medications, partly facilitated by the widespread adoption of telemedicine, have contributed to this trend. Yet, the increasing reliance on SSRIs, a class of antidepressants commonly prescribed for anxiety disorders, has drawn criticism from proponents of the "Make America Healthy Again" (MAHA) movement. They argue that these medications are potentially harmful, a view amplified by figures like Robert F. Kennedy Jr., who heads the Department of Health and Human Services (HHS). During his confirmation hearing, Kennedy controversially compared the difficulty of discontinuing SSRIs to quitting heroin and has more recently suggested his agency is investigating a possible link between SSRIs and violent behaviors, including school shootings. Similarly, Marty Makary, a commissioner with the Food and Drug Administration (FDA), has voiced concerns about potential adverse birth outcomes associated with SSRI use during pregnancy.
However, physicians and researchers widely consider SSRIs like Prozac, Zoloft, and Lexapro to be standard, first-line treatments for various anxiety disorders, including generalized anxiety disorder and panic disorder. They assert that these medications have been unfairly characterized as inherently addictive and damaging, despite extensive evidence supporting their safety for long-term use. Dr. Patrick Kelly, president of the Southern California Psychiatric Society, strongly refutes the criticisms, stating, "The statements about SSRIs are simply not based on any kind of evidence or fact." He highlights that while common side effects can include gastrointestinal upset, concentration difficulties, fatigue, and potential sexual side effects like reduced libido, these are often mild and manageable for many patients. For those suffering from chronic anxiety, the benefits of these medications frequently outweigh the side effects.
Scientific evidence substantiates the efficacy of SSRIs. A recent study indicated that over half of individuals with generalized anxiety disorder experienced at least a 50% reduction in their symptoms when taking an SSRI. While approximately 1 in 12 individuals discontinued the medication due to side effects, the overall positive impact on symptom reduction is significant. Dr. Emily Wood, a psychiatrist practicing in Los Angeles, concurs, noting, "When done properly and also utilizing appropriate therapy techniques, SSRIs can be truly very helpful." She emphasizes that SSRIs are most effective when combined with appropriate therapeutic interventions.
The MAHA movement proposes alternative explanations for the rise in mental health challenges, attributing them in large part to poor dietary choices and sedentary lifestyles. They advocate for solutions such as reducing the consumption of ultra-processed foods, which recent studies have linked to depression and anxiety, and increasing physical activity while decreasing screen time. Psychiatrists generally endorse a healthy diet and regular exercise as complementary therapies for anxiety and depression. Dr. Wood also suggests that individuals who can manage their anxiety without medication should consider talk therapy, noting that anxiety disorders respond exceptionally well to cognitive-behavioral therapy (CBT). This approach has also seen increased utilization, with the proportion of U.S. adults using mental health counseling rising between 2019 and 2024, partly due to the growing popularity of teletherapy.
Despite these alternative approaches, medication remains a critical tool for many. Regarding the concerns about SSRI use during pregnancy, studies suggest that the risks to both mother and baby are low. Dr. Wood points out that untreated depression during pregnancy carries a far greater risk of complications for both. She worries that public pronouncements by government officials about SSRIs in pregnancy could inadvertently cause harm by discouraging women from seeking necessary treatment.
The notion of SSRIs being addictive is largely unfounded. While some individuals may experience withdrawal symptoms like nausea or insomnia upon sudden cessation, particularly if they stop abruptly, the concept of addiction, as defined by compulsive drug-seeking behavior, does not apply to SSRIs. This is in contrast to benzodiazepines, such as Xanax, which are often used as a second-line treatment for anxiety. These controlled substances carry a risk of dependence and can increase the danger of opioid overdose when taken concurrently. Kennedy has also criticized the overuse of benzodiazepines as a significant issue. Dr. Wood explains that while benzodiazepines are effective for acute anxiety, their long-term use can lead to dependence, requiring higher doses for the same effect and necessitating careful, gradual tapering.
An increasing number of individuals are also using beta-blockers, like propranolol, off-label for anxiety. These medications, not FDA-approved for anxiety treatment, are sometimes used to prevent rapid heart rate before public speaking or other high-pressure situations. While they can cause side effects such as dizziness and fatigue, they do not induce addiction and can help regulate the body’s physiological response to stress, shifting from a "fight or flight" state to a more neutral one.
Several societal shifts are believed to be contributing to the overall increase in anxiety and the subsequent rise in medication use. Experts point to factors such as increased social media engagement, greater social isolation, and heightened economic uncertainty. The accessibility of these medications further fuels the trend, with many individuals obtaining prescriptions from primary care physicians or through brief telemedicine consultations.
The normalization of discussions around mental health on social media platforms, led by influencers sharing their own experiences, has played a role in reducing stigma, particularly among younger generations, and encouraging them to seek help. A recent Pew Research Center study indicated that about a third of teenagers use social media for mental health information. However, this increased access to information, coupled with the ease of online searches for medications like Xanax, presents potential pitfalls. While online searches might offer immediate treatment promises, they do not guarantee a prescription and can lead to self-diagnosis based on incomplete or inaccurate information. Dr. Kelly cautions that while increased access is positive, it should not be conflated with purchasing medication online without proper medical supervision.
Younger adults are significantly driving the increase in anxiety medication use. The proportion of Americans aged 18 to 34 taking these medications rose from 8.8% in 2019 to 14.6% in 2024, according to CDC data. This contrasts with a more modest change among older adults. The COVID-19 pandemic and its associated lockdowns demonstrably heightened stress levels, particularly for younger demographics.
The data also consistently shows that women are more likely than men to take anxiety medications. Jason Schnittker, Chair and Professor of Sociology at the University of Pennsylvania, suggests this is due to a confluence of factors: women may be more likely to experience anxiety and more inclined to report it, leading physicians to identify and diagnose anxiety more readily in female patients. Broader societal trends also play a role. Schnittker’s research suggests that anxiety has become increasingly prevalent across successive generations throughout the 20th and 21st centuries. He posits that rising income inequality, increased social isolation replacing communal activities, and a growing distrust of others could all contribute to a pervasive sense of unease.
For Sadia Zapp, the journey with Lexapro was not instantaneous. It took several months before she noticed clear improvements. Her mind felt less cluttered, allowing for better concentration. While she also engaged in therapy, her chronic anxiety is now managed effectively with medication alone. "It definitely helped me get back into my daily routine in a productive way and not just be consumed by anxiety all day," she concluded. The experiences of individuals like Zapp underscore the complex interplay of personal circumstances, societal pressures, and medical interventions in addressing the growing challenge of anxiety in contemporary society.